Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
• To understand the impact of ocrelizumab treatment on neurofilament light (NfL) as a biomarker of neuronal damage in cerebrospinal fluid (CSF) • To assess the number of cluster of differentiation (CD)19+ B cells in CSF (cell number/microliter) before and after treatment with ocrelizumab • To assess the number of CD3+ T cells in CSF (cell number/microliter) before and after treatment with ocrelizumab
Critère d'inclusion
- Relapsing Multiple Sclerosis